Cybertruck Success Comes At A Cost: Tesla Sells Nearly 39,000 Units In 2024, But Luxury Model S And X Sales Take A Hit In US, Data Shows

The rise of Tesla Inc‘s TSLA Cybertruck sales in the U.S. last year weighed heavily upon the company’s other luxury offerings including the Model S sedan and the Model X SUV, according to recent data from automotive research firm Kelley Blue Book.

What Happened: Tesla sold 12,991 Cybertrucks in the fourth quarter of 2024 in the U.S. and 38,965 in the whole year, the data showed. Tesla started delivering the Cybertruck in late November 2023, making 2024 the first whole year of the vehicle’s deliveries.

However, while the company scaled Cybertruck deliveries, its Model S and X sales took a major hit. While Model S sales dropped 31% to 12,426 units last year, Model X sales dropped 20% to 19,855 units.

In fact, the company cumulatively sold just 32,281 Model S and X, or fewer units than the Cybertruck.

Tesla’s overall deliveries in the U.S. dropped by 5.6% year-on-year in 2024 to 633,762 units, spurring its global delivery decline. Sales declined across the company’s lineup of Model 3, X, Y, and S, as per the data.

Tesla does not provide vehicle delivery data by geography, leaving us to rely on third parties for the purpose.

Why It Matters: Despite the year-on-year drop in overall sales, Tesla’s Model Y SUV retained its position as the best-selling EV in the U.S., followed by the Model 3 sedan. Ford’s Mustang Mach-E took third place in the best-selling EVs listicle, followed by the Hyundai Ioniq 5 in fourth place.

Tesla reported its first fall in global annual vehicle deliveries earlier this month. The company delivered 1,789,226 vehicles in 2024, 1.1% less than the 1,808,581 deliveries reported for 2023.

The Forgotten Gold Mine: Hidden Value in Spinoff Stocks

Spinoff stocks have long been cast aside by investors, deemed as unwanted remnants of bigger entities. However, diving deep into the world of spinoffs reveals a treasure trove waiting to be discovered. As investing guru Joel Greenblatt highlights in his timeless masterpiece "You Can Be a Stock Market Genius," these castaways often harbor unrealized potential when set free.

Solventum (SOLV): A Diamond in the Rough

Solventum (NYSE:SOLV) emerges as a promising player in the healthcare landscape after being spun off from industrial giant 3M (NYSE:MMM). With a stronghold in sterilization devices, dressings, tapes, this $8.2 billion revenue giant is ready to conquer. Despite a sluggish start post-separation, boasting revenues of $2 billion and $2.08 per share earnings, the stock remains undervalued. Priced at a discount due to an $8.3 billion debt burden from its previous parent, Solventum is on the path to redemption, making it a beacon in the sea of mediocrity.

Kenvue (KVUE): Unleashing Consumer Power

Kenvue (NYSE:KVUE) struts into the consumer health sector post its emancipation from Johnson & Johnson (NYSE:JNJ). The custodian of iconic brands like Tylenol, Listerine, or Band-Aid, this $15 billion powerhouse flexes its muscles. With a formidable dividend legacy inherited from its erstwhile parent, Kenvue stands tall despite a 24% drop since its inception. Like a phoenix rising from the ashes, Kenvue is poised to soar high on the wings of trust and quality.

W.K. Kellogg (KLG): A Breakfast of Champions

If you had cereal for breakfast, chances are it bore the imprint of W.K. Kellogg (KLG). Stepping out of the shadows of its parent, this stalwart in the breakfast food industry is no stranger to your morning routine. With a legacy as rich as your favorite cornflakes, W.K. Kellogg is a stock to watch, destined to nurture portfolios much like it nurtures bodies.

The Rise of W.K. Kellogg in a Shrinking Cereal Market The Rise of W.K. Kellogg in a Shrinking Cereal Market

However, the company continues to be the best-selling EV brand in the U.S. by a huge margin, followed by Ford who sold just 97,865 EVs last year.

Price Action: Tesla stock is up 2.5% in pre-market trading on Tuesday after Morgan Stanley hiked its price target from $400 to $430 on Monday while maintaining an “overweight” rating.

Tesla has a consensus price target of $294.23 based on the ratings of 34 analysts tracked by Benzinga and a consensus “neutral” rating.

The stock closed up 2.2% at $403.31 on Monday and is up by about 3.4% year-to-date, according to data from Benzinga Pro.

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Read Next:

Image via Tesla

Market News and Data brought to you by Benzinga APIs

Prediction: This Will Be Wall Street’s First $5 Trillion Company — and It’s Not Nvidia

DFAU, KQQQ: Big ETF Inflows

Cybertruck Success Comes At A Cost: Tesla Sells Nearly 39,000 Units In 2024, But Luxury Model S And X Sales Take A Hit In US, Data Shows – Tesla (NASDAQ:TSLA)